ZS Pharma Secures $55,000,000 Series D Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=40de0b74-d652-4b38-9974-eff2f47db3bf - Date
3/6/2014 - Company Name
ZS Pharma - Mailing Address
508 Wrangler Drive Coppell, TX 75019 - Company Description
Founded in 2008, ZS Pharma, Inc. is a privately held specialty pharmaceutical company located inFort Worth, Texas. It is focused on the development and commercialization of proprietary oral sorbent technology that will significantly improve the clinical outcomes of those patients suffering from toxic conditions associated with kidney and liver disease. - Website
http://www.zspharma.com - Transaction Type
Venture Equity - Transaction Amount
$55,000,000 - Transaction Round
Series D - Proceeds Purposes
Proceeds will be used to advance development of ZS-9, the Company’s lead product candidate for the treatment of hyperkalemia, through its New Drug Application (NDA) and Marketing Authorization Application (MAA) submissions in early 2015. - M&A Terms
- Venture Investor
Novo Ventures - Venture Investor
RA Capital - Venture Investor
Adage Capital Management - Venture Investor
Sofinnova Ventures - Venture Investor
Alta Partners - Venture Investor
Devon Park Bioventures - Venture Investor
3×5 Special Opportunity Partners - Venture Investor
Undisclosed
